Top 3 Expensive Stocks in India Based on P/E Ratio. Should You Sell?

By Ekta Sonecha Desai

The Indian stock market has taken a brutal beating. In just one day on 27 January 2025, the Sensex didn’t just fall—it crashed, tumbling over 800 points in a single session and erasing nearly ₹10 lakh crore in investor wealth. Panic swept through Dalal Street as traders watched their screens turn an unforgiving shade of red. Blue-chip stocks bled. Mid-caps and small-caps suffered deeper cuts.

What’s fueling this chaos? A perfect storm of uncertainty. Weak corporate earnings have shaken investor confidence. Foreign institutional investors (FIIs) are pulling out their money, spooked by global volatility. Interest rates remain high, tightening liquidity. Geopolitical tensions, inflation concerns, and a cautious outlook on India’s growth have added to the fear. The once-roaring market, which seemed unstoppable just months ago, now feels fragile and exposed.

Also Read These 2 companies just saw a huge jump in FII holding Motilal Oswal’s top 5 stock picks post Budget 2025 Two defensive stocks set for Bullish Reversal 6 reasons FIIs are selling Indian stocks like there’s no tomorrow…

Not surprisingly, some of the worst hit stocks have been the ones with lofty valuations. Having said that, even after this fall, there are stocks that continue to defy gravity, trading at jaw-dropping valuations as if the market turmoil doesn’t exist. Their Price-to-Earnings (P/E) ratios remain sky-high. Investors are left wondering—are these stocks truly worth their price, or is this another bubble on the verge of bursting?

As Warren Buffett wisely said, “Price is what you pay. Value is what you get.” A stock’s price can be deceiving. Just because it’s expensive doesn’t mean it’s valuable. Investors must look deeper and assess what they’re actually getting in return.

One of the most widely used tools for this is the P/E ratio. It’s a simple yet powerful metric that helps determine whether a stock is overpriced or fairly valued. The formula is straightforward:

P/E Ratio = Market Price per Share / Earnings per Share

A high P/E suggests that investors expect strong future growth. A low P/E could mean the stock is undervalued—or that trouble is brewing.

Let’s take a look at three Indian stocks that are still trading at high P/E ratios despite the market downturn.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain